Antimicrobial properties of Limosilactobacillus reuteri
Reuterin production
L. reuteri is notable for producing an antimicrobial substance called 3-hydroxypropionaldehyde, or reuterin, which it releases into its surroundings. Reuterin effectively inhibits a range of potentially pathogenic bacteria, as well as some viruses and fungi, by inducing oxidative stress through interaction with thiol groups in these pathogens.
Production conditions
The production of reuterin requires an anaerobic environment and glycerol as a substrate. This production is particularly enhanced when L. reuteri comes into close contact with other microorganisms, such as E. coli.
Additional antimicrobial compounds
In addition to reuterin, L. reuteri, like many other lactic acid bacteria, produces lactic acid and acetic acid during the fermentation of various carbohydrates. These acids contribute to inhibiting potential pathogens by creating an environment with a low pH, which is unfavorable for their growth.
Stringent quality standards
From state-of-the-art manufacturing to storage and distribution, we follow strict guidelines. Our quality control measures ensure that every batch meets safety and efficacy standards.
Individually fermented and freeze-dried, the bacteria in our products remain dormant until they encounter saliva and reach a higher temperature, at which point they awaken, are clinically proven to be ‘alive’, and begin their probiotic effects.
Clinically proven safe for all ages
L. reuteri from BioGaia, has been widely studied in clinical trials and has been shown to have probiotic, health-promoting effects in both children and adults.
Numerous studies and meta-analyses have verified the safety of our L. reuteri strains for human consumption among individuals of all ages.
Introducing L. reuteri: One of the world’s most studied probiotic
